Positronen-Emissions-Tomographie

Positron emission tomography (PET) is a radiotracer-based medical imaging technique that detects positron-emitting isotopes to visualize tissue function. PET is widely used to diagnose tumor detection, determine cancer metastases, evaluate heart disease and impaired blood supply, study brain neural activity, and assess infections, bone disease, and thyroid conditions. Unlike static imaging, PET reveals physiologic activity including nutrient metabolism and blood flow.

Radiotracers are biological molecules bound to positron-emitting isotopes like fluorine-18 or carbon-11. When injected into the patient, they accumulate in tissues with higher affinity, such as tumors with elevated metabolic activity. For example, fluorodeoxyglucose (FDG) concentrates in cancer cells because they metabolize glucose differently than normal tissue, allowing PET to detect abnormal regions.

Radioactive fluorine decays and emits positrons, which are positively charged antiparticles of electrons. When positrons combine with nearby electrons, an annihilation reaction occurs, emitting two photons of 511 keV energy in opposite directions. PET detectors collect millions of these annihilation events and use complex computing algorithms to reconstruct detailed images of tracer distribution in the body.

Positron-emitting radioisotopes are produced in a cyclotron through proton bombardment. For example, fluorine-18 is created by bombarding oxygen-18, then incorporated into a glucose analog called fludeoxyglucose (FDG). This tagged compound is then injected intravenously or inhaled as a gas, allowing the scanner to track how tissues utilize the radiotracer.

PET scans reveal physiologic activity, including nutrient metabolism and blood flow, showing how organs function. In contrast, computed tomography and magnetic resonance imaging produce static anatomical images. PET is now typically performed alongside computed tomography or magnetic resonance imaging to provide comprehensive data visualization and improve diagnostic interpretation.

PET can locate regions in the brain that become active during specific activities such as speaking or closing the eyes. By tracking radiotracer accumulation in different brain areas, PET reveals neural activity patterns and can detect brain abnormalities. This functional imaging capability makes PET valuable for studying cognitive processes and diagnosing neurological conditions.

Different radiotracers target specific tissues based on their biological properties. For example, radioactive iodine monitors thyroid function, while radioactive gallium detects cancer. Fluorodeoxyglucose (FDG) reveals glucose metabolism differences between normal and abnormal tissues. This versatility allows PET to diagnose diverse conditions by selecting radiotracers that accumulate in the target organ or pathology.